Six Takeaways from CMS' 2023 Star Ratings

  1. 51% of MA plans with drug coverage will have a four-star rating or higher in 2023
  2. compared with 68% for 2022.
  3. 72% of people currently in an MA drug coverage plan are enrolled in one with four stars or higher
  4. compared to 90% for 2022.
  5. 31% of standalone Part D plans active in 2023 received a star rating of four or more - about 9% of part D plan enrollees are currently in such a plan.
  6. 62 contracts have five stars
  7. with 57 of them as MA prescription drug offerings.
  8. Approximately 72% of the non-profit contracts received 4 or more stars compared to 43% of the for-profit MA-PDs.
  9. Approximately 42% of nonprofit PDPs received 4 or more stars compared to 25% of the for-profit PDPs.